4 months ago
ARGX
AnalystsSamantha SemenkowSamantha Semenkow's Stock Forecasts
AnalystsSamantha Semenkow
Sectors:
Analyst Ranking
Bottom 17%
#4634 out of 5556 analysts
Average Return
-0.23%
Win Rate
47%40 out of 86
Risk vs Reward
Poor
Good
Samantha Semenkow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | +214.16% | $33.06 | $103.86 | 2025-12-17 - 2026-11-06 | Strong Buy |
Roivant Sciences LtdROIV | +178.61% | $12.39 | $34.52 | 2025-09-02 - 2026-09-01 | Strong Buy |
Morphic Holding IncMORF | +109.75% | $27.17 | $56.99 | 2023-12-08 - 2024-08-16 | Strong Buy |
Larimar Therapeutics IncLRMR | +103.34% | $3.29 | $6.69 | 2023-11-17 - 2024-11-15 | Strong Buy |
Roivant Sciences LtdROIV | +97.81% | $18.76 | $37.11 | 2025-10-29 - 2026-10-28 | Strong Buy |
Samantha Semenkow Analyst Color
Get additional color on Samantha Semenkow's coverage of popular stocks
7 months ago
NKTR
8 months ago
NKTR
8 months ago
BIOA
8 months ago
CPRX
9 months ago
ROIV
3 years ago
CABA
3 years ago
EDIT
3 years ago
LRMR
Samantha Semenkow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Roivant Sciences LtdROIV | 7 | Strong Buy | $56.00 | +44.03% | Maintains | 10 days ago |
Argenx SeARGX | 10 | Strong Buy | $1,232.00 | +32.87% | Maintains | 11 days ago |
Dianthus Therapeutics IncDNTH | 1 | Strong Buy | $156.00 | +81.33% | Initiates Coverage On | 2 months ago |
Structure Therapeutics IncGPCR | 3 | Strong Buy | $97.00 | +376.66% | Maintains | 3 months ago |
Rhythm Pharmaceuticals IncRYTM | 4 | Strong Buy | $143.00 | +27.36% | Maintains | 3 months ago |
Wave Life Sciences IncWVE | 4 | Strong Buy | $19.00 | +464.64% | Maintains | 3 months ago |
Agios Pharmaceuticals IncAGIO | 3 | Strong Buy | $52.00 | +76.81% | Maintains | 3 months ago |
Immunovant IncIMVT | 4 | Strong Buy | $61.00 | +99.80% | Maintains | 4 months ago |
Faeth Therapeutics IncFTH | 3 | Strong Buy | $55.00 | +149.43% | Initiates Coverage On | 6 months ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $11.00 | +263.04% | Initiates Coverage On | 6 months ago |
Catalyst Pharmaceuticals IncCPRX | 5 | Hold | $31.50 | +0.03% | Downgrades | 6 months ago |
Spyre Therapeutics IncSYRE | 2 | Strong Buy | $97.00 | -6.61% | Maintains | 6 months ago |
Nektar TherapeuticsNKTR | 3 | Strong Buy | $151.00 | +305.26% | Maintains | 7 months ago |
Biohaven LtdBHVN | 3 | Strong Buy | $17.00 | +17.40% | Maintains | 7 months ago |
Beam Therapeutics IncBEAM | 4 | Strong Buy | $68.00 | +157.48% | Maintains | 7 months ago |
Bioage Labs IncBIOA | 6 | Strong Buy | $52.00 | +873.78% | Maintains | 8 months ago |
Larimar Therapeutics IncLRMR | 7 | Strong Buy | $14.00 | +485.77% | Maintains | 8 months ago |
Cullinan Therapeutics IncCGEM | 1 | Strong Buy | $33.00 | +191.78% | Initiates Coverage On | 9 months ago |
Amicus Therapeutics IncFOLD | 2 | Hold | $14.50 | +0.07% | Downgrades | a year ago |
Prime Medicine IncPRME | 5 | Hold | $4.25 | -8.60% | Maintains | a year ago |
Moonlake ImmunotherapeuticsMLTX | 3 | Strong Sell | $5.00 | N/A | Downgrades | a year ago |
Cabaletta Bio IncCABA | 4 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Acelyrin IncSLRN | 2 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 2 years ago |
Sana Biotechnology IncSANA | 2 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 4 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 3 years ago |
9 Meters Biopharma IncNMTRQ | 3 | Hold | $0.75 | N/A | Maintains | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.